Values of ocular hemodynamics and serum endothelin-1 in the early diagnosis of diabetic retinopathy

National Medical Journal of China

Volumn 93, Issue 1, 2013, Pages 37-40

  Xu, Wei ^a   Wang, Hui Ying ^b   Zhao, Xiao Hu ^b   Wang, Pei Jun ^b  

^a TONGJI UNIVERSITY   (China)

^b NONE

Author keywords

Diabetic retinopathy; Endothelin; Hemodynamics; Ultcasonography, doppler, color

Indexed keywords

ENDOTHELIN 1;

ARTICLE; CARDIOVASCULAR PARAMETERS; CONTROLLED STUDY; CORRELATIONAL STUDY; DATA ANALYSIS; DIABETIC RETINOPATHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE COURSE; EARLY DIAGNOSIS; END DIASTOLIC VELOCITY; FLUORESCENCE ANGIOGRAPHY; HEMODYNAMICS; HUMAN; MAJOR CLINICAL STUDY; OPHTHALMOSCOPE; PEAK SYSTOLIC VELOCITY; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; RADIOIMMUNOASSAY; RESISTANCE INDEX;

ADULT; AGED; CASE-CONTROL STUDIES; DIABETIC RETINOPATHY; DISEASE PROGRESSION; ENDOTHELIN-1; FEMALE; HEMODYNAMICS; HUMANS; MALE; MIDDLE AGED; ULTRASONOGRAPHY, DOPPLER, COLOR;

EID: 84874324308     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0376-2491.2013.01.012     Document Type: Article

References (14)

1. Ding J, Cheung C Y, Ikram M K, et al. Early retinal arteriolar changes and peripheral neuropathy in diabetes. Diabetes Care, 2012, 35: 1098-1104.
2. Battaglia Parodi M, Iacono P, Cascavilla M L, et al. Sequential anterior ischemic optic neuropathy and central retinal artery and vein occlusion after ranibizumab for diabetic macular edema. Eur J Ophthalmol, 2010, 20: 1076-1078.
3. 2004, 20: 41-42.
4. 2005, 13: 335-337.
5. Lockhart C J, McCann A, Agnew C A, et al. Impaired microvascular properties in uncomplicated type 1 diabetes identified by Doppler ultrasound of the ocular circulation. Diab Vasc Dis Res, 2011, 8: 211-220.
6. Wilkinson-Berka J L. Angiotensin and diabetic retinopathy. Int J Biochem Cell Biol, 2006, 38: 752-765.
7. Crosby-Nwaobi R, Heng L Z, Sivaprasad S. Retinal vascular calibre, geometry and progression of diabetic retinopathy in type 2 diabetes mellitus. Ophthalmologica, 2012, 228: 84-92.
8. Ergul A. Endothelin-1 and diabetic complications: focus on the vasculature. Pharmacol Res, 2011, 63: 477-482.
9. Thorin E, Webb D J. Endothelium-derived endothelin-1. Pflugers Arch, 2010, 459: 951-968.
10. Yanagisawa M, Kurihara S, Kimura S, et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature, 1988, 332: 411-415.
11. Clermont A C, Bursell S E. Retinal blood flow in diabetes. Microcirculation, 2007, 14: 49-61.
12. Fernández-Durango R, Rollín R, Mediero A, et al. Localization of endothelin-1 mRNA expression and immunoreactivity in the anterior segment of human eye: expression of ETA and ETB receptors. Mol Vis, 2003, 9: 103-109.
13. Cellini M, Strobbe E, Gizzi C, et al. ET-1 plasma levels and ocular blood flow in retinitis pigmentosa. Can J Physiol Pharmacol, 2010, 88: 630-635.
14. Takagi C, Bursell S E, Lin Y W, et al. Regulation of retinal hemodynamics in diabetic rats by increased expression and action of endothelin-1. Invest Ophthalmol Vis Sci, 1996, 37: 2504-2518.